The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Retention and activity of BMP‐2 in hyaluronic acid‐based scaffolds in vitro
Open accessAbstract
Bone morphogenetic protein‐2 (BMP‐2) delivered in a suitable implantable matrix has the potential to repair local skeletal defects by inducing new bone formation from undifferentiated plurpotent stem cells resident in host tissue. In this study, we examined in vitro the potential of a derivatized hyaluronic acid (Hyaff‐11) scaffold as a delivery vehicle for recombinant human BMP‐2 (rhBMP‐2) in bone and cartilage repair therapies. Hyaff‐11 scaffolds were fabricated using a phase inversion/particulate leaching method and soak‐loaded with rhBMP‐2. In vitro release kinetics of rhBMP‐2, demonstrated using enzyme‐linked immunosorbant assay and alkaline phosphatase (ALP) assay revealed a slow, sustained rhBMP‐2 release during 28 days, with a cumulative release of 31.82% of the initial rhBMP‐2 loaded. rhBMP‐2 was released in bioactive form as demonstrated by ALP induction of pluripotent cell line, C3H10T1/2 (T1/2), down the osteoblast lineage when incubated with the release supernatants. rhBMP‐2 retention in Hyaff‐11 scaffolds was greater than that from collagen gels, which released most of the initially loaded rhBMP‐2 by 14 days. rhBMP‐2‐loaded Hyaff‐11 scaffolds were also seeded with T1/2 cells and evaluated at 3, 7, 14, and 28 days for viability and expression of osteoblast phenotype. Cells remained viable throughout the study and expressed a time‐ and dose‐dependent ALP and osteocalcin expression in the rhBMP‐2 groups. Based on these observations, Hyaff‐11 scaffolds may be suitable delivery systems for rhBMP‐2 in bone/cartilage repair because of their ability to retain rhBMP‐2, release low levels of bioactive rhBMP‐2 to the local environment in a sustained manner, and stimulate differentiation of pluripotent stem cells. © 2001 Wiley Periodicals, Inc. J Biomed Mater Res 59: 573–584, 2002
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of polyphosphazenes for skeletal tissue regeneration
Laurencin, C. T., Norman, M. E., Elgendy, H. M., El‐Amin, S. F., Allcock, H. R., Pucher, S. R., & Ambrosio, A. A. (1993) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820270716 · Cited by 179
Cited by
Porosity of 3D biomaterial scaffolds and osteogenesis
Karageorgiou, V., & Kaplan, D. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.002 · Cited by 6,622
Hydrogels for tissue engineering: scaffold design variables and applications
Drury, J. L., & Mooney, D. J. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00340-5 · Cited by 5,136
Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size
Loh, Q. L., & Choong, C. (2013) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2012.0437 · Cited by 2,668
Electrospun silk-BMP-2 scaffolds for bone tissue engineering
Li, C., Vepari, C., Jin, H.-J., Kim, H. J., & Kaplan, D. L. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.022 · Cited by 1,140
Self-citationA Review of the Clinical Side Effects of Bone Morphogenetic Protein-2
James, A. W., LaChaud, G., Shen, J., Asatrian, G., Nguyen, V., Zhang, X., Ting, K., & Soo, C. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0357 · Cited by 1,131
Hyaluronic acid based scaffolds for tissue engineering—A review
Collins, M. N., & Birkinshaw, C. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.10.028 · Cited by 1,092
Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering
Lee, S.-H., & Shin, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.016 · Cited by 706
Strategies for controlled delivery of growth factors and cells for bone regeneration
Vo, T. N., Kasper, F. K., & Mikos, A. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.016 · Cited by 666
Smart polymeric gels: Redefining the limits of biomedical devices
Chaterji, S., Kwon, I. K., & Park, K. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.018 · Cited by 615
Bessa, P. C., Casal, M., & Reis, R. L. (2008) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.74 · Cited by 549
The application of hyaluronic acid in bone regeneration
Zhai, P., Peng, X., Li, B., Liu, Y., Sun, H., & Li, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.169 · Cited by 438
Leach, J. B., & Schmidt, C. E. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.02.018 · Cited by 430
Schmidt, M. B., Chen, E. H., & Lynch, S. E. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.10.011 · Cited by 415
Vascularized Bone Tissue Engineering: Approaches for Potential Improvement
Nguyen, L. H., Annabi, N., Nikkhah, M., Bae, H., Binan, L., Park, S., Kang, Y., Yang, Y., & Khademhosseini, A. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2012.0012 · Cited by 313
Advanced biomaterials for skeletal tissue regeneration: Instructive and smart functions
Barrère, F., Mahmood, T. A., de Groot, K., & van Blitterswijk, C. A. (2008) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2007.12.001 · Cited by 303
Design of cell–matrix interactions in hyaluronic acid hydrogel scaffolds
Lam, J., Truong, N. F., & Segura, T. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.07.025 · Cited by 286
Kempen, D. H. R., Lu, L., Hefferan, T. E., Creemers, L. B., Maran, A., Classic, K. L., Dhert, W. J. A., & Yaszemski, M. J. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.031 · Cited by 276
Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration
El Bialy, I., Jiskoot, W., & Reza Nejadnik, M. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2147-x · Cited by 257
Metadata
- Authors
- Kim, H. D., & Valentini, R. F.
- Venue
- Journal of Biomedical Materials Research
- Publisher
- Wiley
- Published
- 2001-12-05
- Volume
- 59
- Issue
- 3
- Pages
- 573-584
- ISSN
- 0021-9304 (ISSN-L)
- 1097-4636
- OpenAlex
- W2088773289
- Cited by
- 185
- References
- 1
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.